Nachtsheim DA, Rearden A. nolvadex while on cycle Approximately 22,000 postmenopausal women, 35 years of age or older, who are at increased risk for developing breast cancer will be randomly assigned in this double-blind trial to receive either 20 mg of tamoxifen plus a placebo or 60 mg of raloxifene plus a placebo, for five years.
Апартаменты
Выезд
0 Нравится
Пожаловаться
В избранное
